Loading…
Recognizing the Importance of Critical Minerals in Healthcare Act of 2023
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
93pct
417d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2024 · fourth_quarter · Health Issues
HR 1199/S 1544, Facilitating Innovative Nuclear Diagnostics Act of 2023, all provisions. S 866, American Innovation and Jobs Act, all provisions. HR 2673, American Innovation and R&D Competitiveness Act of 2023, all provisions. HR 3851/S 2464, Access to Breast Cancer Diagnosis Act of 2023, all provisions. HR 3086, Find It Early Act, all provisions. HR 1526/S 765, Reducing Hereditary Cancer Act, all provisions. HR 3305/S 1606, Black Maternal Health Momnibus Act, all provisions. HR 6395, Recognizing the Importance of Critical Minerals in Healthcare Act of 2023, all provisions. HR 8816, American Medical Innovation and Investment Act of 2024, all provisions. S 4638, National Defense Authorization Act for Fiscal Year 2025, provisions related to government contracting. Issues impacting artificial intelligence. Issues impacting corporate taxation. Issues impacting funding for health care including government research. Issues impacting health care and public health. Issues impacting manufacturing. Issues impacting medical device and health care cybersecurity. Issues impacting medical device regulation. Issues impacting medical insurance coverage. Issues impacting medical research. Issues impacting Medicare coverage and reimbursement for medical technology and health care services. Issues impacting servicing and repair of medical devices. Issues impacting wireless spectrum. Issues impacting international trade and supply chains. Issues impacting Veterans health.
Became Public Law No: 118-233.
Became Public Law No: 118-233.
Signed by President.
Signed by President.
Presented to President.
Presented to President.
Message on Senate action sent to the House.
Passed Senate without amendment by Unanimous Consent. (consideration: CR S7275)
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
Senate Committee on Energy and Natural Resources discharged by Unanimous Consent.
Senate Committee on Energy and Natural Resources discharged by Unanimous Consent.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $220,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
2024 · fourth_quarter · Energy/Nuclear
H.R. 8046 - Rosatom Sanctions Enforcement Act H.R. 6395 - Recognizing the Importance of Critical Minerals in Healthcare Act of 2023 H.R. 6815 - Nuclear Medicine Clarification Act Proposed legislation to reauthorize the DOE Isotope Program Appropriations for DOE isotope production NRC rules impacting the use of radiopharmaceuticals
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
HR 1199/S 1544, Facilitating Innovative Nuclear Diagnostics Act of 2023, all provisions. S 866, American Innovation and Jobs Act, all provisions. HR 2673, American Innovation and R&D Competitiveness Act of 2023, all provisions. HR 3851/S 2464, Access to Breast Cancer Diagnosis Act of 2023, all provisions. HR 3086, Find It Early Act, all provisions. HR 1526/S 765, Reducing Hereditary Cancer Act, all provisions. HR 3305/S 1606, Black Maternal Health Momnibus Act, all provisions. HR 6395, Recognizing the Importance of Critical Minerals in Healthcare Act of 2023, all provisions. HR 8816, American Medical Innovation and Investment Act of 2024, all provisions. HR 8070, Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025, provisions related to government contracting. S 4638, National Defense Authorization Act for Fiscal Year 2025, provisions related to government contracting. Issues impacting artificial intelligence. Issues impacting corporate taxation. Issues impacting funding for health care including government research. Issues impacting health care and public health. Issues impacting manufacturing. Issues impacting medical device and health care cybersecurity. Issues impacting medical device regulation. Issues impacting medical insurance coverage. Issues impacting medical research. Issues impacting Medicare coverage and reimbursement for medical technology and health care services. Issues impacting servicing and repair of medical devices. Issues impacting wireless spectrum. Issues impacting international trade and supply chains. Issues impacting Veterans health.
Client expense: $80,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
2024 · third_quarter · Energy/Nuclear
H.R. 8046 - Rosatom Sanctions Enforcement Act H.R. 6395 - Recognizing the Importance of Critical Minerals in Healthcare Act of 2023 H.R. 6815 - Nuclear Medicine Clarification Act Proposed legislation to reauthorize the DOE Isotope Program Appropriations for DOE isotope production NRC rules impacting the use of radiopharmaceuticals
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
HR 1199/S 1544, Facilitating Innovative Nuclear Diagnostics Act of 2023, all provisions. S 866, American Innovation and Jobs Act, all provisions. HR 2673, American Innovation and R&D Competitiveness Act of 2023, all provisions. HR 3851/S 2464, Access to Breast Cancer Diagnosis Act of 2023, all provisions. HR 3086, Find It Early Act, all provisions. HR 1526/S 765, Reducing Hereditary Cancer Act, all provisions. HR 3305/S 1606, Black Maternal Health Momnibus Act, all provisions. HR 6395, Recognizing the Importance of Critical Minerals in Healthcare Act of 2023, all provisions. HR 8816, American Medical Innovation and Investment Act of 2024, all provisions. Issues impacting artificial intelligence. Issues impacting corporate taxation. Issues impacting funding for health care including government research. Issues impacting health care and public health. Issues impacting manufacturing. Issues impacting medical device and health care cybersecurity. Issues impacting medical device regulation. Issues impacting medical insurance coverage. Issues impacting medical research. Issues impacting Medicare coverage and reimbursement for medical technology and health care services. Issues impacting servicing and repair of medical devices. Issues impacting wireless spectrum. Issues impacting international trade and supply chains. Issues impacting Veterans health.
Client expense: $190,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
2024 · second_quarter · Financial Institutions/Investments/Securities
Issues related to the regulatory outcomes and proposed rules resulting from the Dodd-Frank Issues related to Export-Import Bank Issues related to corporate governance S.4049/H.R.6395, National Defense Authorization Act
Client expense: $2,660,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
2024 · second_quarter · Energy/Nuclear
H.R. 8046 - Rosatom Sanctions Enforcement Act H.R. 6395 - Recognizing the Importance of Critical Minerals in Healthcare Act of 2023 H.R. 6815 - Nuclear Medicine Clarification Act Proposed legislation to reauthorize the DOE Isotope Program Appropriations for DOE isotope production NRC rules impacting the use of radiopharmaceuticals
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Financial Institutions/Investments/Securities
Issues related to the regulatory outcomes and proposed rules resulting from the Dodd-Frank Issues related to Export-Import Bank Issues related to corporate governance S.4049/H.R.6395, National Defense Authorization Act
Client expense: $2,370,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
2023 · fourth_quarter · Financial Institutions/Investments/Securities
Issues related to the regulatory outcomes and proposed rules resulting from the Dodd-Frank Issues related to Export-Import Bank Issues related to corporate governance S.4049/H.R.6395, National Defense Authorization Act
Client expense: $2,780,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
2023 · third_quarter · Telecommunications
Issues relating to broadband access, competition, and funding. Issues relating to the wireless industry, such as spectrum technologies, spectrum management, infrastructure, and competition. Issues related to the promotion and deployment of Open RAN technologies, including the Open RAN grant programs authorized in H.R. 6395 (National Defense Authorization Act for Fiscal Year 2021) and funded in H.R. 4346 (the CHIPS and Science Act of 2022). H.R. 3565 (Spectrum Auction Reauthorization Act of 2023), H.R. 1338 (the Satellite and Telecommunications Streamlining Act), H.R. 682 (the Launch Communications Act), H.R. 1353 (the Advanced, Local Emergency Response Technology Strategy Act), H.R. 4510 (NTIA Reauthorization Act of 2023), H.R. 4512 (Digital Economy Cybersecurity Advisory Act), H.R. 4513 (Commerce Spectrum Coordination Act of 2023), H.R. 4504 (Novel, Advanced, Spectrum and Communications Technology Networks Promotion Act), H.R. 4505 (PLAN For Broadband Act), H.R. 2670 (National Defense Authorization Act for Fiscal Year 2024), S. 1648 (Launch Communication Act), S. 2855 (CLOSE THE GAP Act), and S. 2226 (National Defense Authorization Act for Fiscal Year 2024).
Client expense: $680,000 · Firm income: Not reported
2023 · third_quarter · Financial Institutions/Investments/Securities
Issues related to the regulatory outcomes and proposed rules resulting from the Dodd-Frank Issues related to Export-Import Bank Issues related to corporate governance S.4049/H.R.6395, National Defense Authorization Act
Client expense: $2,130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
2023 · second_quarter · Financial Institutions/Investments/Securities
Issues related to the regulatory outcomes and proposed rules resulting from the Dodd-Frank Issues related to Export-Import Bank Issues related to corporate governance S.4049/H.R.6395, National Defense Authorization Act
Client expense: $2,050,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
2023 · second_quarter · Telecommunications
Issues relating to broadband access, competition, and funding. Issues relating to the wireless industry, such as spectrum technologies, spectrum management, infrastructure, and competition. Issues related to the promotion and deployment of Open RAN technologies, including the Open RAN grant programs authorized in H.R. 6395 (the National Defense Authorization Act for Fiscal Year 2021) and funded in H.R. 4346 (the CHIPS and Science Act of 2022). H.R. 3565 (Spectrum Auction Reauthorization Act of 2023), H.R. 1338 (the Satellite and Telecommunications Streamlining Act), H.R. 682 (the Launch Communications Act), H.R. 1353 (the Advanced, Local Emergency Response Technology Strategy Act), H.R. 4510 (NTIA Reauthorization Act of 2023), H.R. 4512 (Digital Economy Cybersecurity Advisory Act), H.R. 4513 (Commerce Spectrum Coordination Act of 2023), H.R. 4504 (Novel, Advanced, Spectrum and Communications Technology Networks Promotion Act), H.R. 4505 (PLAN For Broadband Act), and S. 1648 (Launch Communication Act).
Client expense: $640,000 · Firm income: Not reported
2023 · first_quarter · Financial Institutions/Investments/Securities
Issues related to the regulatory outcomes and proposed rules resulting from the Dodd-Frank Issues related to Export-Import Bank Issues related to corporate governance S.4049/H.R.6395, National Defense Authorization Act
Client expense: $1,870,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
2023 · first_quarter · Telecommunications
Issues relating to broadband access, competition, and funding. Issues relating to the wireless industry, such as spectrum technologies, spectrum management, infrastructure, and competition. Issues related to the promotion and deployment of Open RAN technologies, including the Open RAN grant programs authorized in H.R. 6395 (the National Defense Authorization Act for Fiscal Year 2021) and funded in H.R. 4346 (the CHIPS and Science Act of 2022). Monitored additional Open RAN provisions in H.R. 7776, the National Defense Authorization Act for Fiscal Year 2023. S. 1260 (United States Innovation and Competition Act), H.R. 4521 (America COMPETES Act), and H.R. 7624 (Spectrum Innovation Act). H.R. 1338 (the Satellite and Telecommunications Streamlining Act), H.R. 682 (the Launch Communications Act), H.R. 1353 (the Advanced, Local Emergency Response Technology Strategy Act), H.R. 1340 (the Open RAN Outreach Act), and H.R. 1108 (to extend spectrum auction authority).
Client expense: $620,000 · Firm income: Not reported
Received in the Senate and Read twice and referred to the Committee on Energy and Natural Resources.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H6267)
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H6267)
DEBATE - The House proceeded with forty minutes of debate on H.R. 6395.
Considered under suspension of the rules. (consideration: CR H6267–6268)
Mr. Tiffany moved to suspend the rules and pass the bill.
Placed on the Union Calendar, Calendar No. 602.
Reported by the Committee on Natural Resources. H. Rept. 118-710.
Congress.gov source codes: 5000, H12200
Ordered to be Reported by Unanimous Consent.
Committee Consideration and Mark-up Session Held
Subcommittee on Energy and Mineral Resources Discharged
Subcommittee Hearings Held
Referred to the Subcommittee on Energy and Mineral Resources.
Referred to the House Committee on Natural Resources.
Introduced in House
Congress.gov source codes: 1000, Intro-H
| House |
| Markup By |
| June 12, 2024 |
| Natural Resources Committee | House | Discharged from | June 12, 2024 |
| Natural Resources Committee | House | Referred To | November 14, 2023 |
| October 22, 2024 |
| Introduced in House | November 14, 2023 |
| Enrolled Bill | -- |
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office